IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — CHR

Balance Sheet

(in millions USD)
MetricQ2 2025Q2 2024Q2 2023Q2 2021
Cash & Equivalents203.23186.09152.4420.31
Short-term Investments------1.73
Accounts Receivable86.2479.8267.16115.75
Total Current Assets323.54314.00246.98161.45
Property, Plant & Equipment0.020.050.120.27
Intangible Assets38.7818.1818.0314.84
Total Non-current Assets39.2119.2419.3343.87
Total Assets362.75333.24266.30205.32
Accounts Payable1.482.674.9936.75
Short-term Debt7.58------
Total Current Liabilities39.0445.4833.2564.56
Total Non-current Liabilities1.521.620.203.19
Total Liabilities40.5647.0933.4567.75
Retained Earnings214.88193.58159.43105.79
Total Stockholder Equity322.11286.07232.78137.15

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2025Q2 2024Q2 2023Q2 2021
Total Revenue70.9971.0667.4471.90
Cost of Revenue20.7718.89----
Gross Profit50.2252.17----
Research & Development2.331.360.640.34
Selling, General & Admin4.241.612.272.32
Total Operating Expenses*(59.24)40.5358.7255.68
Operating Income8.3211.648.7116.21
Interest Expense----(0.03)0.24
Pretax Income7.7511.848.8416.95
Tax Provision-0.00(0.58)0.040.03
Net Income7.7612.428.7516.92
Basic EPS0.671.230.120.27
Diluted EPS0.671.230.120.27

* Derived from reported values

Cash Flow Statement

(in millions USD)
MetricQ2 2025Q2 2024Q2 2023Q2 2021
Operating Cash Flow3.92(6.74)27.18(11.89)
Capital Expenditures--0.00----
Free Cash Flow*--(6.74)----
Investing Cash Flow----(0.06)1.68
Financing Cash Flow(2.12)2.9760.0112.53

* Derived from reported values